Sechenov School
Home › Pharmacology › Mast Cell Stabilizers

Mast Cell Stabilizers

*Cromones*

For medical students2 min readUpdated 2026-10-10

Mast cell stabilizers are a group of anti-allergic medications used for maintenance therapy. They prevent the disruption of sensitized cells and the release of inflammatory mediators, making them effective exclusively for prophylaxis rather than for managing acute attacks.

Core RuleProphylaxis only; these drugs do not relieve established bronchospasm.
Onset of ActionEffects develop gradually, reaching maximum efficacy in 1–4 weeks.
MechanismBlockade of calcium or chloride channels in the cell membrane.
Clinical UseBronchial asthma, allergic rhinitis, and allergic conjunctivitis.

Mechanism of Action and Pharmacodynamics

The primary goal of stabilizers is to prevent sensitized mast cells from rupturing (degranulating) upon contact with an allergen. If the cell membrane remains intact, inflammatory and allergic mediators—such as histamine, leukotrienes, prostaglandins, and platelet-activating factor (PAF)—are not released.

In pharmacology, there are two main views on this process:

In addition to their direct action on mast cells, cromones exhibit supplementary pharmacodynamic effects. They suppress the chemotaxis of immune cells to the site of inflammation, reduce cytokine release from eosinophils and T-lymphocytes, and inhibit the cough reflex. The latter property is particularly valuable in exercise-induced bronchospasm or bronchospasm triggered by inhaling cold air.

Cromoglicic Acid and Nedocromil

These are typical representatives of the group, designed primarily for topical administration.

Cromoglicic acid has a bis-chromone structure featuring two carboxyl groups that impart acidic properties.

Nedocromil sodium differs significantly in chemical structure, but works pharmacologically in a similar manner. About 8–17% is absorbed into the bloodstream, and the maximum prophylactic effect develops faster—by the end of the first week of regular use. It is prescribed 4 times daily.

Ketotifen: A Drug with Mixed Action

Ketotifen stands out markedly from inhaled cromones. It is a tricyclic compound (containing nitrogen and sulfur atoms in the central ring) with a dual mechanism of action:

  1. Stabilizes mast cell membranes.
  2. Blocks type 1 histamine receptors (similar to classical antihistamines).

It is important to remember that despite its antihistamine activity, ketotifen does not cause bronchodilation and is not suitable for relieving acute attacks.

Mnemonic

Remember the golden rule of cromones with the analogy: "Cromones are like an umbrella: open it before the rain." They protect against an allergic reaction only when taken in advance and are completely useless if the "downpour" (acute bronchospasm) has already started.

Frequently asked questions

Why does cromoglicic acid rarely cause systemic side effects?

The drug has low solubility and is poorly absorbed from mucous membranes (only 5–15% of the dose reaches the bloodstream). Consequently, its effects remain predominantly local.

Can ketotifen be used to relieve an acute asthma attack?

No, ketotifen does not cause bronchial dilation. Like other drugs in this class, it is used exclusively for the baseline prevention of attacks.

How quickly do inhaled cromoglicic acid treatments take effect?

The drug's effect develops gradually. Maximum therapeutic efficacy is achieved only after 2–4 weeks of systematic use.

Go deeper

More topics in Pharmacology

Vitamin-Like Compounds and Plant VitaminsAmitriptylineAromatic Compounds in PharmacologyClopidogrelRenin-Angiotensin System Inhibitors: Pharmacology and Mechanism of ActionPentazocineGold CompoundsValidolAntiparkinsonian DrugsIntramuscular and Subcutaneous InjectionsDemulcentsAtropinePharmacology →